| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/01/2010 | CN101821251A Chiral cis-imidazolines |
| 09/01/2010 | CN101821247A 5-(2-hydroxy phenyl)tetrazole compound as hsp90 inhibitor for anticancer |
| 09/01/2010 | CN101821243A Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 09/01/2010 | CN101820950A Biphenylcarboxamide derivatives as hedgehog pathway modulators |
| 09/01/2010 | CN101820919A Injectable polymer-lipid blend for localized drug delivery |
| 09/01/2010 | CN101820915A Methods and compositions for treating cancers |
| 09/01/2010 | CN101820913A Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 09/01/2010 | CN101820910A Antibodies binding to an intracellular prl-1 or prl-3 polypeptide |
| 09/01/2010 | CN101820894A VHZ for diagnosis and treatment of cancer |
| 09/01/2010 | CN101820892A Treatment regime for proliferative disorders |
| 09/01/2010 | CN101820875A Pharmaceutical formulations containing lipoic acid derivatives |
| 09/01/2010 | CN101818152A Ribonucleic acid taking liver cancer related gene DLK1 as target spot and application thereof |
| 09/01/2010 | CN101817940A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same |
| 09/01/2010 | CN101817882A Light-chain variable region and heavy-chain variable region of FMU-EPCAM-4E4 monoclonal antibody |
| 09/01/2010 | CN101817829A 4-substituted anilino-podophyllotoxine derivative and application |
| 09/01/2010 | CN101817813A Crystal IV of 3-(substituted dihydroisoindolinone-2-yl)-2,6-piperidinediketone and medicinal composite thereof |
| 09/01/2010 | CN101817805A Andrographolide derivative and preparation method and application thereof |
| 09/01/2010 | CN101817787A Androgen receptor antagonist for resisting prostate cancer |
| 09/01/2010 | CN101816797A Gold nanoparticles used as medicament carrier and method for preparing same |
| 09/01/2010 | CN101816795A Nanometer magnetic control throat anesthesia compound preparation and use thereof |
| 09/01/2010 | CN101816794A Antitumor agents |
| 09/01/2010 | CN101816792A Combinations comprising epothilones and pharmaceutical uses thereof |
| 09/01/2010 | CN101816788A Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/01/2010 | CN101816779A Human nuclear clusterin, vector and application thereof |
| 09/01/2010 | CN101816777A Novel Boanmycin composition and preparation method thereof |
| 09/01/2010 | CN101816761A Chinese medicinal composition for treating liver cancer and preparation method thereof |
| 09/01/2010 | CN101816755A Complex agent for treating cancer |
| 09/01/2010 | CN101816744A Energy-saving and environmentally-friendly method for preparing garlic oil cyclodextrine inclusion compound |
| 09/01/2010 | CN101816702A Lung cancer preventing and treating composition extracted from selfheal and/or garden orache and application thereof in preparation of lung cancer preventing and treating medicine |
| 09/01/2010 | CN101816685A Hydroxyl-containing acid extract for preventing and treating prostate cancer, and extraction method and application thereof |
| 09/01/2010 | CN101816665A Immunosuppressive medicament |
| 09/01/2010 | CN101816659A Anti-tumor medicament |
| 09/01/2010 | CN101816653A Application of berberine in preparing tumor radio sensitization medicine |
| 09/01/2010 | CN101816651A Medicinal application of compound and medicine preparation thereof |
| 09/01/2010 | CN101816649A Preparation method of 2,3-indolediketone-3-oxime and application in prevention and control of cancer |
| 09/01/2010 | CN101816647A Extracting and purifying method of diterpene coumarin ether and application thereof |
| 09/01/2010 | CN101816644A Composition of taxol and phenylalanine and preparation method thereof |
| 09/01/2010 | CN101816633A Microsphere sustained-release preparation for preventing and curing cancers and application thereof |
| 09/01/2010 | CN101816631A Liposome preparation for tumor therapeutic vaccine and preparation method thereof |
| 09/01/2010 | CN101816629A Dual target liposome and preparation method and application thereof |
| 09/01/2010 | CN101816626A Pharmaceutical compositions and dosage forms of thalidomide |
| 09/01/2010 | CN101428148B RGD polypeptide radiopharmaceuticals and preparation method thereof |
| 09/01/2010 | CN101337928B Quinoline compounds, synthesizing method, applications in synthesis of alkaloid of camptothecins |
| 09/01/2010 | CN101297672B Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal |
| 09/01/2010 | CN101284107B Medicine for curing cancers and preparation method thereof |
| 09/01/2010 | CN101254217B Preparation of extract of regeneratabl portion of yew and applications of same for preparing oral anti-cancer medicine |
| 09/01/2010 | CN101250132B Polyfluoro ortho-hydroxybenzamide derivatives and uses thereof |
| 09/01/2010 | CN101209349B Application of carbon nano-tube as carrier in transferring anti-cancer medicine |
| 09/01/2010 | CN101116668B Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients proteurs de cancers multiples |
| 09/01/2010 | CN101074229B 7-azaindirubin and 7-azaisoindigo derivative production and pharmaceutical use |
| 09/01/2010 | CN101041078B Biology agent for improving radiosensitization of tumor cells and the use thereof |
| 08/31/2010 | USRE41614 Synthetic analogs of ecteinascidin-743 |
| 08/31/2010 | US7786299 Methods for treating diseases or conditions using dihydropteridinone compounds |
| 08/31/2010 | US7786282 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents |
| 08/31/2010 | US7786278 improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer; carcinoembryonic antigen (CEA) |
| 08/31/2010 | US7786271 Antibodies that inhibit TSLP activity |
| 08/31/2010 | US7786269 The antibodies or fragments specifically bind to an extracellular epitope of an Epstein Barr Virus latent membrane protein; anticarcinogenic agents; cancer vaccines |
| 08/31/2010 | US7786151 Inhibiting SF2/ASF-dependent splicing of beta-globin pre-mRNA in vitro by suppression of Clk-mediated phosphorylation of SR proteins (serine/arginine-rich); a benzothiazole, TG003, is inhibitor of Clk/Sty(CDC2-like kinases); anticancer, antitumor; neurodegenerative diseases |
| 08/31/2010 | US7786135 Substituted pyrroline kinase inhibitors |
| 08/31/2010 | US7786132 1-(2-{4-[5-(2-Azetidin-1-yl-ethoxy)-benzo[b]thiophen-2-y1]-5-bromo-pyrimidin-2-ylamino}-ethyl)-5,5-dimethyl-imidazolidine-2,4-dione, useful for treating diseases mediated by polo-like kinase, selected from rheumatoid arthritis and breast cancer, in a mammals; antiproliferative agents |
| 08/31/2010 | US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders |
| 08/31/2010 | US7786127 Antineoplastic agents; polo like kinase effectors; such as 3-{[1-(2-chlorophenyl)ethyl]oxy}-5-[6-(1-piperizinemethyl)-1H-benzimidazol-1-yl]-2-thiophenecarboxamide |
| 08/31/2010 | US7786118 Temozolomide FDA Orange book listed patent; water soluble, and storage stable formulation; L-threonine as dissolution enhancer |
| 08/31/2010 | US7786112 Small molecule antiproliferative agents |
| 08/31/2010 | US7786098 (Z)-1-(3,4,5-trimethoxyphenyl)-2-(3'-amino-4'-trifluoroethoxyphenyl)-ethene, used to inhibit the polymerization of microtubules and for the treatment of tumor and neovascularization; anticarcinogenic agents |
| 08/31/2010 | US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 08/31/2010 | US7785887 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes |
| 08/31/2010 | US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease |
| 08/31/2010 | US7785873 Antigen arrays for treatment of bone disease |
| 08/31/2010 | US7785870 Cell-specific expression/replication vector |
| 08/31/2010 | US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use |
| 08/31/2010 | US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 08/31/2010 | US7785817 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 08/31/2010 | US7785811 Using lutetium label probes to detect tumor secreted antigens and diagnose/prognose cell proliferative disorders |
| 08/31/2010 | US7785791 Polypeptide variants with altered effector function |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/31/2010 | US7785579 enhancing the tumoricidal activity of an isolated TNF protein comprising bonding to the TNF to polyethyleneglycol; increased circulating half-life of the TNF while not increasing its toxicity; antitumor or anticarcinogenic agents with reduced side effects |
| 08/31/2010 | CA2618271C Novel cyclohexenone compounds from antrodia camphorata and application thereof |
| 08/31/2010 | CA2549558C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/31/2010 | CA2540639C Salts and polymorphs of a pyrrole-substituted indolinone compound |
| 08/31/2010 | CA2389545C Chemokine receptor binding heterocyclic compounds |
| 08/31/2010 | CA2332817C Il-6 antagonist peptides |
| 08/31/2010 | CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes |
| 08/31/2010 | CA2259478C New salts of anionic complexes of ru(iii), as antimetastatic and antineoplastic agents |
| 08/27/2010 | CA2656679A1 Use of ginseng fractions for preventing or reducing hematological malignancies |
| 08/26/2010 | WO2010096838A2 Proproteins and methods of use thereof |
| 08/26/2010 | WO2010096791A1 (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives |
| 08/26/2010 | WO2010096790A1 (+)-morphinananium n-oxides and processes for their production |
| 08/26/2010 | WO2010096788A1 (+)-morphinanium quaternary salts and processes for their production |
| 08/26/2010 | WO2010096719A2 Anticancer and antimicrobial compounds from antarctic extremophilic microorganisms |
| 08/26/2010 | WO2010096603A2 Cancer-targeting peptides and uses thereof in cancer therapy |
| 08/26/2010 | WO2010096539A1 Methods for treating lipomas and liposarcomas |
| 08/26/2010 | WO2010096486A1 Methods and kits for diagnosis of cancer and prediction of therapeutic value |
| 08/26/2010 | WO2010096466A2 Methods and compositions for inhibiting cellular proliferation and surgical adhesion |
| 08/26/2010 | WO2010096314A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS |
| 08/26/2010 | WO2010095965A1 The use of sulindac and/or its metabolite as adjuvant treatment for colon cancer in humans |
| 08/26/2010 | WO2010095940A2 Glutathione-based drug delivery system |
| 08/26/2010 | WO2010095879A2 Sirna to be bound to transcripts of apoptosis-related genes, and compositions for treating cancer using same |
| 08/26/2010 | WO2010095706A1 Novel anti-inflammatory compounds |
| 08/26/2010 | WO2010095663A1 Fused heterocyclic ring compound |